Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Shares Sold by Franklin Resources Inc.

Franklin Resources Inc. decreased its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 51.5% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 51,076 shares of the company’s stock after selling 54,152 shares during the quarter. Franklin Resources Inc. owned 0.05% of Acadia Healthcare worth $2,025,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also recently bought and sold shares of the company. Nisa Investment Advisors LLC boosted its holdings in shares of Acadia Healthcare by 40.7% in the fourth quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company’s stock worth $41,000 after buying an additional 301 shares during the period. Pacer Advisors Inc. boosted its stake in Acadia Healthcare by 2.4% in the 4th quarter. Pacer Advisors Inc. now owns 13,847 shares of the company’s stock worth $549,000 after purchasing an additional 325 shares during the period. Tidal Investments LLC grew its position in Acadia Healthcare by 7.9% during the 3rd quarter. Tidal Investments LLC now owns 4,664 shares of the company’s stock worth $296,000 after purchasing an additional 340 shares in the last quarter. Blue Trust Inc. lifted its holdings in shares of Acadia Healthcare by 69.4% in the fourth quarter. Blue Trust Inc. now owns 842 shares of the company’s stock valued at $33,000 after purchasing an additional 345 shares in the last quarter. Finally, Coldstream Capital Management Inc. lifted its stake in Acadia Healthcare by 7.5% in the 3rd quarter. Coldstream Capital Management Inc. now owns 6,167 shares of the company’s stock worth $391,000 after acquiring an additional 430 shares in the last quarter.

Acadia Healthcare Stock Performance

NASDAQ ACHC opened at $26.15 on Monday. The company’s fifty day moving average is $33.22 and its two-hundred day moving average is $40.94. Acadia Healthcare Company, Inc. has a 52-week low of $25.41 and a 52-week high of $82.41. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07. The firm has a market capitalization of $2.43 billion, a price-to-earnings ratio of 8.57, a P/E/G ratio of 1.46 and a beta of 1.13.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on the company. Royal Bank of Canada reduced their price objective on Acadia Healthcare from $64.00 to $43.00 and set an “outperform” rating for the company in a research report on Monday, March 3rd. TD Cowen dropped their price target on shares of Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating on the stock in a research note on Tuesday, January 7th. Guggenheim began coverage on shares of Acadia Healthcare in a research note on Wednesday, April 9th. They issued a “buy” rating and a $36.00 price objective for the company. StockNews.com downgraded shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Monday, January 6th. Finally, KeyCorp reduced their price target on Acadia Healthcare from $70.00 to $65.00 and set an “overweight” rating for the company in a research report on Monday, March 3rd. One analyst has rated the stock with a sell rating, three have issued a hold rating and six have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Acadia Healthcare has an average rating of “Moderate Buy” and an average price target of $50.39.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.